No Data
No Data
Organon & Co. (NYSE:OGN) Is a Favorite Amongst Institutional Investors Who Own 80%
Key Insights Significantly high institutional ownership implies Organon's stock price is sensitive to their trading actions The top 15 shareholders own 50% of the company Ownership research along
Express News | NYSE Order Imbalance 104610.0 Shares on Buy Side
Express News | NYSE Order Imbalance 56041.0 Shares on Buy Side
Express News | NYSE Order Imbalance 107268.0 Shares on Buy Side
Express News | European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (Denosumab) Biosimilar Candidate Hlx14
Organon & Co Spearheads Kahn Brothers' Strategic Portfolio Enhancements in Q1 2024